AlphaStocks
2.2
Avoid

RadNet, Inc. (RDNT)

Health Care / Health Care Services

S&P SmallCap 600

$55.30

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 4 of 5 models — moderate confidence

#1079out of 1127 in Health Care

Is RadNet, Inc. a Good Investment in 2026?

RadNet, Inc. (RDNT) scores 2.2 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Greenblatt Magic Formula model rates RadNet, Inc. as Attractive (Top half (rank 50%)). However, the Lynch model rates it Caution. RadNet, Inc. currently trades above its estimated fair value of $24, suggesting limited upside at current prices. RadNet, Inc. ranks #1079 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-1.7Market Cap4B

Estimated Fair Value

$23.96131% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Caution

Business quality & competitive moat

Graham

Caution

Price vs intrinsic value

Lynch

Caution

Growth rate vs price (PEG)

Greenblatt

Attractive

Top half (rank 50%)

Frequently Asked Questions

Is RadNet, Inc. (RDNT) a good investment?
Based on AlphaStocks' composite analysis, RadNet, Inc. (RDNT) scores 2.2 out of 10, earning a Avoid rating. This score is below average, suggesting caution. Trading above estimated fair value — the market may be pricing in future growth.
What is RadNet, Inc.'s Piotroski F-Score?
RadNet, Inc.'s Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is RDNT overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $24, RDNT appears overvalued. The stock currently trades 131% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does RDNT compare to other Health Care stocks?
RadNet, Inc. ranks #1079 out of 1127 stocks in the Health Care sector, placing it in the top 96% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about RDNT?
AlphaStocks evaluates RDNT using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Caution; Lynch: Caution; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 2.2/10.

Similar Stocks

PARRFTIAZN

Compare RDNT with

RDNT vs PARRRDNT vs FTIRDNT vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer